Zimmer Biomet to Present at 37th Annual J.P. Morgan Healthcare Conference
WARSAW, Ind., Dec. 18, 2018
WARSAW, Ind., Dec. 18, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday, January 8, 2019 at 10:00 a.m. Pacific Time.
A live webcast of the presentation can be accessed via Zimmer Biomet's Investor Relations website at http://investor.zimmerbiomet.com. The webcast will be archived for replay following the conference.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
View original content to download multimedia:http://www.prnewswire.com/news-releases/zimmer-biomet-to-present-at-37th-annual-jp-morgan-healthcare-conference-300768121.html
SOURCE Zimmer Biomet Holdings, Inc.